The Latest Breaking News from NYSE

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022

Upgrades

Benzinga · Mar 24, 2022

Paymentus Holdings's Return On Capital Employed Overview

According to Benzinga Pro, during Q4, Paymentus Holdings (NYSE:PAY) earned $4.67 million, a 1005.45% increase from the preceding quarter. Paymentus Holdings also posted a total of $108.13 million in sales, a 6.35% increase since Q3.

Benzinga · Mar 24, 2022

Boyd Gaming Earnings Perspective: Return On Capital Employed

Pulled from Benzinga Pro data, Boyd Gaming (NYSE:BYD) showed a loss in earnings since Q3, totaling $109.78 million. Sales, on the other hand, increased by 4.36% to $879.84 million during Q4.

Benzinga · Mar 24, 2022

Netflix Rival Adds Live Sports To Its Streaming Bouquet

Netflix Inc's (NASDAQ:NFLX) Swedish rival NENT, which looked to foray into Britain later this year with its streaming service Viaplay, added live sports to its content line-up in the country. NENT also secured long-term exclusive rights in Britain to sporting events such as ice hockey, skating, and handball from various sports organizations. Also…

Benzinga · Mar 24, 2022

FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer

The FDA approved Novartis AG's (NYSE:NVS) Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to treat patients with a type of advanced prostate cancer that has spread to other parts of the body. Pluvicto is a targeted radioligand therapy for adult patients who have already undergone other anticancer treatments. The company said it had submitted…

Benzinga · Mar 24, 2022

Quest Diagnostics Secures CDC Contract To Support COVID-19 Research

The Centers for Disease Control and Prevention (CDC) has granted a contract to Quest Diagnostics Inc (NYSE:DGX) to perform testing and provide laboratory data analysis to help identify patterns in SARS-COV-2 seroprevalence on a multistate basis.  Quest was awarded the contract following a competitive bid. The total contract value with all options is valued…

Benzinga · Mar 24, 2022

Darden Restaurants' Q3 Earnings Miss Estimates Bitten By Omicron

Darden Restaurants Inc (NYSE:DRI) reported third-quarter FY22 sales growth of 41.3% year-on-year, to $2.45 billion, missing the consensus of $2.51 billion. Same-restaurant sales increased 38.1%. Darden clocked an operating margin of 12.3%, and the operating income jumped 103.4% Y/Y to $301 million. EBITDA was $395 million. EPS of $1.93 missed the consensus of…

Benzinga · Mar 24, 2022

Why Uber Shares Are Surging

Uber Technologies Inc (NYSE: UBER) shares are trading higher Thursday morning following a Wall Street Journal report indicating the company has reached a deal to list all New York

Benzinga · Mar 24, 2022

Recap: TD Synnex Q1 Earnings

  TD Synnex (NYSE:SNX) reported its Q1 earnings results on Thursday, March 24, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 24, 2022

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Mar 24, 2022